The authors analyzed MMP-9 activity and serum concentrations of OPG, d-dimer, homocysteine and C-reactive protein as the possible indicators of leaks in patients with AAA undergoing endovascular aneurysm repair. The gene discussed is MMP9; the disease is triple-A syndrome.